GO:0015919 peroxisomal membrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015919 peroxisomal membrane transport describes the directed movement of substances to, from, or across the peroxisomal membrane.
• It encompasses both protein import (matrix and membrane proteins) and metabolite transport (fatty acids, cofactors, cholesterol).
• Key protein components include PEX3, PEX19, PEX5, PEX7, ABCD1, and PMP70, which mediate targeting, docking, and translocation.
• Recent studies reveal that peroxisomal protein import involves phase separation and a nuclear pore-like phase, challenging classical views.
• Defects in peroxisomal membrane transport cause devastating diseases such as X-linked adrenoleukodystrophy and Zellweger spectrum disorders.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect the molecular mechanisms and disease relevance of this process.
Description
Peroxisomal membrane transport (GO:0015919) is a fundamental biological process that governs the exchange of proteins and metabolites across the peroxisomal membrane. Peroxisomes are single-membrane organelles involved in fatty acid oxidation, ether lipid synthesis, and reactive oxygen species metabolism. The peroxisomal membrane acts as a selective barrier, and its transport systems ensure that the organelle receives its correct complement of matrix and membrane proteins while allowing the import of substrates and export of products. This process is essential for cellular homeostasis, and its dysfunction leads to severe metabolic disorders. Understanding peroxisomal membrane transport is therefore critical for researchers studying organelle biogenesis, lipid metabolism, and related diseases. The directed movement of substances to, from, or across the peroxisomal membrane is mediated by a suite of peroxins (PEX proteins) and membrane transporters. Recent advances have revealed unexpected mechanisms, such as phase separation and a nuclear pore-like phase during protein import, highlighting the dynamic and complex nature of this process. This article provides a comprehensive overview of the molecular players, regulatory mechanisms, and experimental approaches to study peroxisomal membrane transport.
peroxisomal membrane transport At A Glance
| GO ID | GO:0015919 |
|---|---|
| GO term | peroxisomal membrane transport |
| Ontology | biological_process |
| Synonym | None |
| Major function | Directed movement of substances to, from, or across the peroxisomal membrane |
| Key components | PEX3, PEX19, PEX5, PEX7, ABCD1, PMP70, and other peroxins and transporters |
| Associated diseases | X-linked adrenoleukodystrophy, Zellweger spectrum disorders, and other peroxisomal biogenesis disorders |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, proteomics, imaging, and biochemical transport assays |
What Is GO:0015919?
GO:0015919 peroxisomal membrane transport is defined as the directed movement of substances to, from, or across the peroxisomal membrane. This includes the import of cytosolic proteins into the peroxisomal matrix or membrane, the transport of metabolites such as fatty acids and cofactors across the membrane, and the export of products. The process is highly selective and energy-dependent, involving a network of peroxins and membrane proteins.
Why Is peroxisomal membrane transport Important in Cell Biology?
Peroxisomal membrane transport is vital for cellular metabolism and organelle function. It ensures the proper import of enzymes required for fatty acid oxidation and plasmalogen synthesis, and the transport of metabolites such as cholesterol and cofactors. Defects in this process cause a spectrum of diseases, including X-linked adrenoleukodystrophy and Zellweger syndrome, which can be fatal. Studying peroxisomal membrane transport provides insights into organelle biogenesis, membrane dynamics, and metabolic regulation, and offers potential therapeutic targets.
• Maintains peroxisomal metabolic functions, including fatty acid beta-oxidation and ether lipid synthesis.
• Enables the import of matrix proteins that carry peroxisomal targeting signals (PTS1 and PTS2).
• Regulates cholesterol transport through lysosome-peroxisome membrane contacts.
• Facilitates the transport of cofactors such as ATP, NAD+, and coenzyme A.
• Dysfunction leads to X-linked adrenoleukodystrophy due to ABCD1 mutations.
• Impaired protein import causes Zellweger spectrum disorders, often fatal in infancy.
• Involved in cellular redox balance and reactive oxygen species detoxification.
• Emerging evidence links peroxisomal transport to neurodegeneration and aging.
• Target for therapeutic interventions in peroxisomal disorders.
• Provides a model for studying membrane protein targeting and organelle biogenesis.
What Happens During peroxisomal membrane transport?
Protein Targeting and Docking
In simple terms: Proteins destined for the peroxisome are recognized in the cytosol and dock at the membrane.
Cytosolic proteins with peroxisomal targeting signals (PTS1 or PTS2) are recognized by receptors PEX5 and PEX7, respectively. These receptor-cargo complexes then dock at the peroxisomal membrane via interactions with PEX13, PEX14, and PEX17. This docking step is essential for subsequent translocation.
Translocation and Import
In simple terms: The cargo proteins are moved across the membrane into the peroxisome.
After docking, the receptor-cargo complex undergoes a conformational change that facilitates translocation. Recent studies suggest that this process involves phase separation and a nuclear pore-like phase, where the peroxisomal membrane forms a transient pore for protein import. The receptor PEX5 is monoubiquitinated and recycled back to the cytosol, while the cargo is released into the matrix.
Metabolite Transport
In simple terms: Small molecules like fatty acids and cofactors are moved across the peroxisomal membrane.
Metabolite transport across the peroxisomal membrane is mediated by specific transporters. For example, ABCD1 (ALDP) transports very long-chain fatty acids into peroxisomes for beta-oxidation. Other transporters include PMP70 (ABCD3) for fatty acids and PEX11 for membrane dynamics. Cholesterol transport occurs through membrane contacts between lysosomes and peroxisomes. Cofactor transport, such as ATP and NAD+, is also essential for peroxisomal functions.
Membrane Dynamics and Biogenesis
In simple terms: The peroxisomal membrane grows and divides to form new peroxisomes.
Peroxisomal membrane transport is tightly linked to peroxisome biogenesis and dynamics. PEX11 proteins mediate membrane elongation and division, while PEX3 and PEX19 are involved in membrane protein insertion. The import of membrane proteins such as PMP70 and PEX11 is crucial for maintaining membrane integrity and function.
Key Genes Involved in GO:0015919 peroxisomal membrane transport
The following genes encode key proteins involved in peroxisomal membrane transport, including peroxins, membrane transporters, and associated factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PEX3 | Peroxisomal membrane protein assembly; docking factor | Essential for peroxisome biogenesis; mutations cause Zellweger spectrum |
| PEX19 | Cytosolic receptor for membrane proteins; chaperone | Targets membrane proteins to peroxisomes; defects lead to peroxisomal disorders |
| PEX5 | Cytosolic receptor for PTS1 proteins | Mediates matrix protein import; mutations cause peroxisomal biogenesis disorders |
| PEX7 | Cytosolic receptor for PTS2 proteins | Involved in import of a subset of matrix proteins; defects cause rhizomelic chondrodysplasia punctata |
| PEX13 | Docking protein at peroxisomal membrane | Forms part of the docking complex; mutations linked to Zellweger syndrome |
| PEX14 | Docking protein; interacts with PEX5 and PEX7 | Central to protein import; essential for peroxisome function |
| ABCD1 | Peroxisomal membrane transporter for very long-chain fatty acids | Mutations cause X-linked adrenoleukodystrophy |
| ABCD3 (PMP70) | Peroxisomal membrane transporter for fatty acids | Involved in fatty acid transport; potential link to metabolic disorders |
| PEX11B | Membrane elongation and division | Regulates peroxisome proliferation; defects affect organelle dynamics |
| PEX16 | Membrane protein import and peroxisome biogenesis | Mutations cause Zellweger spectrum; involved in early steps |
| PEX10 | RING finger peroxin; ubiquitination of PEX5 | Required for receptor recycling; mutations cause peroxisomal disorders |
| PEX12 | RING finger peroxin; ubiquitination of PEX5 | Similar to PEX10; essential for import |
| PEX2 | RING finger peroxin; ubiquitination of PEX5 | Involved in receptor recycling; defects cause Zellweger syndrome |
| PEX26 | Recruits PEX6/PEX1 to membrane | Required for receptor recycling; mutations cause peroxisomal disorders |
| PEX1 | AAA-ATPase; receptor recycling | Mutations are common in Zellweger spectrum |
| PEX6 | AAA-ATPase; receptor recycling | Works with PEX1; defects cause peroxisomal biogenesis disorders |
| PEX18 | Accessory factor for PTS2 import (yeast) | Model for studying PTS2 pathway; not in humans |
| PEX21 | Accessory factor for PTS2 import (yeast) | Similar to PEX18; yeast-specific |
How Is peroxisomal membrane transport Regulated?
Peroxisomal membrane transport is regulated at multiple levels. The expression of PEX genes is controlled by transcription factors such as PPARα, which responds to fatty acid levels. Additionally, the import process is regulated by ubiquitination and recycling of receptors (PEX5, PEX7) via the RING finger peroxins (PEX2, PEX10, PEX12) and AAA-ATPases (PEX1, PEX6). Recent studies suggest that phase separation of PEX5 and other components may regulate the dynamics of the import pore. Metabolite transport is also regulated by substrate availability and membrane lipid composition.
peroxisomal membrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCD1 | X-linked adrenoleukodystrophy | ABCD1 knockout mice; patient-derived fibroblasts; CRISPR point mutations |
| PEX1 | Zellweger spectrum disorder | PEX1 knockout cell lines; knock-in of patient mutations |
| PEX7 | Rhizomelic chondrodysplasia punctata | PEX7 knockout mice; overexpression of mutant PEX7 |
| PEX10 | Zellweger spectrum disorder | CRISPR knockout in HEK293; point mutation knock-in |
| PEX5 | Peroxisomal biogenesis disorder | PEX5 knockout cells; tagged knock-in for imaging |
X-linked Adrenoleukodystrophy (X-ALD)
X-ALD is caused by mutations in the ABCD1 gene, which encodes a peroxisomal membrane transporter for very long-chain fatty acids. Defective transport leads to accumulation of VLCFAs in plasma and tissues, causing demyelination and adrenal insufficiency. This highlights the critical role of peroxisomal membrane transport in lipid metabolism and neurodegeneration.
Zellweger Spectrum Disorders
Zellweger spectrum disorders are a group of peroxisomal biogenesis disorders caused by mutations in PEX genes, such as PEX1, PEX6, PEX10, PEX12, and PEX26. These mutations impair protein import into peroxisomes, leading to severe developmental and neurological abnormalities. The severity ranges from Zellweger syndrome (fatal in infancy) to milder forms.
Rhizomelic Chondrodysplasia Punctata (RCDP)
RCDP is caused by mutations in PEX7, which is required for the import of PTS2-containing proteins. This leads to defects in plasmalogen synthesis and skeletal abnormalities. It demonstrates the specificity of peroxisomal membrane transport pathways.
Other Metabolic Disorders
Defects in peroxisomal membrane transport have been linked to other conditions, including cholesterol transport defects and cofactor transport deficiencies. For example, impaired cholesterol transport through lysosome-peroxisome contacts may contribute to metabolic diseases.
From peroxisomal membrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of ABCD1 in VLCFA transport? | ABCD1 knockout cell line (e.g., HEK293) and rescue with wild-type or mutant ABCD1 |
| How do PEX5 mutations affect protein import? | Point mutation knock-in of patient-derived PEX5 mutations in cell lines |
| Where is PEX14 localized during import? | Tagged knock-in of PEX14 with fluorescent protein (e.g., GFP) for live imaging |
| Does overexpression of PEX11B increase peroxisome abundance? | Overexpression of PEX11B in mammalian cells followed by imaging |
| What is the effect of PEX7 deficiency on plasmalogen synthesis? | PEX7 knockout mice or cell lines; lipidomics analysis |
| Can CRISPR screening identify novel regulators of peroxisomal transport? | Genome-wide CRISPR knockout library screening in reporter cells |
How to Study the peroxisomal membrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function phenotypes | Identify novel regulators of peroxisomal transport |
| Proximity labeling (BioID) | Protein-protein interactions | Map interactome of peroxins and transporters |
| Live-cell imaging | Dynamics of import and membrane changes | Visualize PEX5 translocation and phase separation |
| Lipidomics | Lipid composition and VLCFA levels | Assess ABCD1 function and peroxisomal beta-oxidation |
| RNA-seq | Transcriptional changes | Measure PEX gene expression under different conditions |
| Proteomics | Protein abundance and modifications | Quantify peroxisomal proteins in disease models |
| In vitro transport assay | Transport kinetics | Measure fatty acid or cholesterol transport |
| Yeast genetics | Functional conservation of peroxins | Study PTS1 and PTS2 import pathways |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate peroxisomal membrane transport. For example, a reporter cell line expressing a fluorescent peroxisomal marker can be used to isolate mutants with defects in import or membrane dynamics.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify protein-protein interactions among peroxins and transporters. Proximity labeling (BioID) can map the interactome of membrane proteins in living cells.
Imaging and Live-Cell Analysis
Fluorescence microscopy of tagged peroxisomal proteins (e.g., PEX14-GFP) allows real-time visualization of import and membrane dynamics. Super-resolution microscopy can resolve the nuclear pore-like phase during import.
Biochemical Transport Assays
In vitro transport assays using isolated peroxisomes or proteoliposomes can measure the kinetics of metabolite transport. For example, radiolabeled fatty acids can be used to assess ABCD1-mediated transport.
How CRISPR Can Be Used to Study GO:0015919 peroxisomal membrane transport
Knockout
CRISPR knockout of PEX genes or ABCD1 in cell lines (e.g., HEK293, HeLa) can create models of peroxisomal disorders. These models are used to study the loss of transport function, accumulation of metabolites, and cellular phenotypes. For example, ABCD1 knockout cells accumulate very long-chain fatty acids and can be used to test therapeutic compounds.
Point Mutation
Introducing patient-specific point mutations (e.g., in PEX1, PEX6, or ABCD1) via CRISPR knock-in allows researchers to study the molecular basis of disease. These models can reveal subtle defects in protein stability, interactions, or transport activity that are not apparent in complete knockouts.
Knock-in
Tagged knock-in of peroxisomal proteins (e.g., PEX14-GFP, PEX5-HaloTag) enables live-cell imaging and proteomic analysis. This approach preserves endogenous regulation and provides insights into the spatiotemporal dynamics of peroxisomal membrane transport.
Overexpression
Overexpression of peroxisomal transporters or peroxins (e.g., PEX11B, ABCD1) can be achieved by CRISPR activation (CRISPRa) or lentiviral transduction. This is useful to study gain-of-function effects, such as increased peroxisome proliferation or enhanced fatty acid transport.
How EDITGENE Supports peroxisomal membrane transport Research
Researchers studying peroxisomal membrane transport-related genes often need to determine whether a candidate gene is causally involved in the process, and to dissect its molecular function. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous investigation of peroxisomal membrane transport mechanisms and their role in disease.
Contact EDITGENE today to design your custom CRISPR model for peroxisomal membrane transport research.
Frequently Asked Questions About peroxisomal membrane transport
What is peroxisomal membrane transport?
Peroxisomal membrane transport (GO:0015919) is the directed movement of substances to, from, or across the peroxisomal membrane, including proteins and metabolites.
What genes are involved in peroxisomal membrane transport?
Key genes include PEX3, PEX19, PEX5, PEX7, ABCD1, ABCD3 (PMP70), and other PEX genes encoding peroxins.
How does protein import into peroxisomes work?
Cytosolic proteins with PTS1 or PTS2 signals are recognized by PEX5 or PEX7, dock at the membrane via PEX13/PEX14, and translocate through a dynamic pore that may involve phase separation.
What diseases are linked to peroxisomal membrane transport defects?
X-linked adrenoleukodystrophy (ABCD1), Zellweger spectrum disorders (PEX genes), and rhizomelic chondrodysplasia punctata (PEX7) are linked to defects in peroxisomal membrane transport.
How can I study peroxisomal membrane transport using CRISPR?
CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression models can be used to dissect gene function and disease mechanisms.
What is the role of ABCD1 in peroxisomal membrane transport?
ABCD1 encodes a peroxisomal membrane transporter that imports very long-chain fatty acids for beta-oxidation; mutations cause X-linked adrenoleukodystrophy.
What is the role of PEX5 in peroxisomal membrane transport?
PEX5 is the cytosolic receptor for PTS1-containing proteins and mediates their import into the peroxisomal matrix.
How is peroxisomal membrane transport regulated?
It is regulated by receptor ubiquitination and recycling (PEX2, PEX10, PEX12, PEX1, PEX6), transcription factors like PPARα, and possibly phase separation.
What methods are used to study peroxisomal membrane transport?
Common methods include CRISPR screens, live-cell imaging, proteomics, lipidomics, and in vitro transport assays.
Can peroxisomal membrane transport be targeted therapeutically?
Yes, understanding the transport mechanisms may lead to therapies for peroxisomal disorders, such as gene therapy or small molecule chaperones.
Conclusion
Peroxisomal membrane transport (GO:0015919) is a vital cellular process that ensures the proper exchange of proteins and metabolites across the peroxisomal membrane. It is mediated by a complex network of peroxins and transporters, and its dysfunction leads to severe human diseases. Recent discoveries of phase separation and nuclear pore-like phases have revolutionized our understanding of protein import. Continued research using CRISPR-based models and advanced technologies will further elucidate the mechanisms and pave the way for therapeutic interventions.
References
- 1. Chu BB et al.. 2015. Cholesterol transport through lysosome-peroxisome membrane contacts.. Cell 161(2):291-306 PMID: 25860611
- 2. Plett A et al.. 2020. Peroxisomal Cofactor Transport.. Biomolecules 10(8) PMID: 32806597
- 3. Visser WF et al.. 2007. Metabolite transport across the peroxisomal membrane.. Biochem J 401(2):365-75 PMID: 17173541
- 4. Girzalsky W et al.. 2009. Protein transport across the peroxisomal membrane.. Biol Chem 390(8):745-51 PMID: 19558328
- 5. Ravindran R et al.. 2023. Peroxisome biogenesis initiated by protein phase separation.. Nature 617(7961):608-615 PMID: 37165185
- 6. Gao Y et al.. 2022. Protein import into peroxisomes occurs through a nuclear pore-like phase.. Science 378(6625):eadf3971 PMID: 36520918
- 7. Hettema EH et al.. 2000. Transport of fatty acids and metabolites across the peroxisomal membrane.. Biochim Biophys Acta 1486(1):18-27 PMID: 10856710
- 8. Platta HW et al.. 2007. Peroxisomal dynamics.. Trends Cell Biol 17(10):474-84 PMID: 17913497
